Prognostic Role of Serum Adrenomedullin in Patients with Ventilator Associated Pneumonia.
adrenomedullin
mortality
prolonged mechanical ventilation
sepsis
septic shock
ventilator associated pneumonia
Journal
Advances in respiratory medicine
ISSN: 2543-6031
Titre abrégé: Adv Respir Med
Pays: Switzerland
ID NLM: 101697329
Informations de publication
Date de publication:
18 Aug 2022
18 Aug 2022
Historique:
received:
04
07
2022
revised:
31
07
2022
accepted:
12
08
2022
entrez:
25
8
2022
pubmed:
26
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
Ventilator associated pneumonia is a common type of sepsis that occurs to about 9-27% of all mechanically ventilated patients and 20-50% of them develop septic shock. Several clinical, laboratory, and radiological methods have been used for diagnosing VAP. Adrenomedullin (ADM) has been found to be elevated in the plasma of septic patients. The study aim was to explore the prognostic role of ADM in the VAP patients. A prospective observational study. Intensive Care Department of Alexandria University Hospitals. A total of 140 patients with proven VAP after medical ICU admission were consecutively enrolled. APACHE II score, SOFA score, CRP, lactate, and serum ADM were measured at day 0 of VAP diagnosis and 5 days later. The results were correlated with the outcomes of patients. APACHE II, lactate, and serum ADM on day 0 could predict an unfavorable outcome. ADM prediction power was significantly higher than APACHE II and lactate. Day 5 readings of all tested parameters could predict occurrence of the unfavorable outcome. ADM on day 0 showed the highest sensitivity (96.25%). Serum adrenomedullin when measured at days 0 and 5 of VAP diagnosis may serve as an early predictor of unfavorable outcome.
Identifiants
pubmed: 36004964
pii: arm90040044
doi: 10.3390/arm90040044
pmc: PMC9717343
doi:
Substances chimiques
Lactates
0
Adrenomedullin
148498-78-6
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
349-359Références
Clin Infect Dis. 2016 Sep 1;63(5):e61-e111
pubmed: 27418577
J Thorac Dis. 2016 Jul;8(7):1388-90
pubmed: 27501243
Clin Chem Lab Med. 2013 Jun;51(6):1167-75
pubmed: 23392907
Am J Respir Crit Care Med. 2005 Feb 15;171(4):388-416
pubmed: 15699079
Crit Care. 2008;12(2):R56
pubmed: 18426596
Chest. 2017 Aug;152(2):312-320
pubmed: 28411114
J Bras Pneumol. 2021 Jun 23;47(3):e20200569
pubmed: 34190861
Crit Care. 2014 Feb 17;18(1):R34
pubmed: 24533868
Crit Care. 2019 Nov 29;23(1):387
pubmed: 31783881
Crit Care. 2014 Mar 18;18(2):208
pubmed: 25029020
Am J Respir Crit Care Med. 1999 Jul;160(1):132-6
pubmed: 10390390
Crit Care. 2011;15(6):238
pubmed: 22152031
Eur Respir J. 2005 May;25(5):804-12
pubmed: 15863636
Front Immunol. 2018 Feb 19;9:292
pubmed: 29520277
South Med J. 2008 Dec;101(12):1222-6
pubmed: 19005450
Exp Clin Endocrinol Diabetes. 1997;105(3):156-62
pubmed: 9228512
Eur Respir J. 2010 Apr;35(4):805-11
pubmed: 19717486
JAMA. 2007 Apr 11;297(14):1583-93
pubmed: 17426278
Int J Infect Dis. 2015 Jan;30:144-7
pubmed: 25461659
Respiration. 2006;73(4):503-8
pubmed: 16205047
Biomed Res Int. 2013;2013:960101
pubmed: 23984422
Ann Transl Med. 2020 Jun;8(11):670
pubmed: 32617290
Front Pharmacol. 2019 May 09;10:482
pubmed: 31143118
J Crit Care. 2012 Oct;27(5):523.e1-9
pubmed: 21958973
Scand J Trauma Resusc Emerg Med. 2017 Jul 14;25(1):69
pubmed: 28705203
Crit Care Med. 2013 Feb;41(2):580-637
pubmed: 23353941